Brugada Syndrome

Brugada SyndromeCreated OnApril 21, 2020Last Updated OnOctober 28, 2020byadmin You are here: Main ECG Brugada Syndrome < All Topics Table of Contents It causes high incidence of sudden death in patients with structurally normal hearts due to a mutation in the cardiac sodium channel gene Clinical Manifestations: Syncope, VT, VF, sudden death at sleep Diagnosis: Diagnosis requires 2 parts (ECG findings + clinical findings) Typical ECG abnormalities in V1 and V2 (coved type: more common) Clinical characteristics, one of the following: History of VT/VF Family Hx of sudden cardiac death Family Hx of coved-type ECG Agonal respirations during sleep Inducible VT/VF during EP study Take-home Points: Be thorough in evaluating an ECG Look closely at all 12 leads! Sometimes the answer is in the “quiet” complexes If there are different morphologies on the ECG, look at all of the morphologies! Don’t give sodium channel blockers to patients with Brugada syndrome (or hyperkalaemia). Typical sodium channel blockers (lidocaine, amiodarone, procainamide) could be dangerous! *We do not own this ECG, it’s for knowledge sharing purpose

Continue reading

Please Login/Register to read full article.